CATX News - Candlesense

Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors

(CATX) SEATTLE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatm...

Board

7 days ago

Perspective Therapeutics to Participate in Upcoming September Conferences

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for...

Investor

15 days ago

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results

SEATTLE, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pionee...

What technical chart patterns or momentum indicators are emerging following the earnings announcement? Is there any insider trading activity or significant institutional positioning revealed around the release date? What macro or sector‑specific factors (e.g., reimbursement policy, FDA activity) could amplify or mitigate the impact of this news on the stock?

Earnings

28 days ago